Angiotensin converting enzyme 2 in the kidney

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 4, 2008, Pages 420-425

  Koitka, A ^a   Cooper, M E ^a   Thomas, M C ^a   Tikellis, C ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Angiotensin 1 7; Angiotensin converting enzyme 2; Angiotensin II; Diabetes; Hypertension; Renal impairment; Rennin angiotensin system

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7]; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ACE2 GENE; ALBUMINURIA; ANIMAL TISSUE; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; DISEASE EXACERBATION; ENZYME LOCALIZATION; FOCAL GLOMERULOSCLEROSIS; GENE; GLOMERULONEPHRITIS; HOMEOSTASIS; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; MOUSE; NEPHRECTOMY; NEPHRITIS; NONHUMAN; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; DIABETES MELLITUS; HUMANS; KIDNEY; KIDNEY DISEASES; PEPTIDYL-DIPEPTIDASE A;

EID: 40149086849     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.04889.x     Document Type: Conference Paper

References (61)

1. Crowley SD, Gurley SB, Oliverio MI et al. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J. Clin. Invest. 2005 115 : 1092 9.
2. Donoghue M, Hsieh F, Baronas E et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 2000 87 : E1 9.
3. Turner AJ, Hooper NM. The angiotensin-converting enzyme gene family: Genomics and pharmacology. Trends Pharmacol. Sci. 2002 23 : 177 83.
4. Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem. J. 2004 383 : 45 51.
5. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme - Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 2000 275 : 33 238 43.
6. Coates D, Isaac RE, Cotton J et al. Functional conservation of the active sites of human and Drosophila angiotensin I-converting enzyme. Biochemistry 2000 39 : 8963 9.
7. Harmer D, Gilbert M, Borman R, Clark KL. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 2002 532 : 107 10.
8. Paizis G, Tikellis C, Cooper ME et al. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 2005 54 : 1790 6.
9. Tikellis C, Johnston CI, Forbes JM et al. Identification of angiotensin converting enzyme 2 in the rodent retina. Curr. Eye Res. 2004 29 : 419 27.
10. Strawn WB, Richmond RS, Ann TE, Gallagher PE, Ferrario CM. Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells. Br. J. Haematol. 2004 126 : 120 6.
11. Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME. Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat. Diabetes 2004 53 : 989 97.
12. Vickers C, Hales P, Kaushik V et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 2002 277 : 14 838 43.
13. Li W, Moore MJ, Vasilieva N et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003 426 : 450 4.
14. Nishiyama A, Seth DM, Navar LG. Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 2002 39 : 129 34.
15. Stockand JD, Sansom SC. Glomerular mesangial cells: Electrophysiology and regulation of contraction. Physiol. Rev. 1998 78 : 723 44.
16. Oliver JD 3rd, Anderson S, Troy JL, Brenner BM, Deen WH. Determination of glomerular size-selectivity in the normal rat with Ficoll. J. Am. Soc. Nephrol. 1992 3 : 214 28.
17. Ren Y, Garvin JL, Carretero OA. Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension 2002 39 : 799 802.
18. Sampaio WO, Nascimento AA, Santos RA. Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats. Am. J. Physiol. Heart Circ Physiol. 2003 284 : H1985 94.
19. Handa RK, Ferrario CM, Strandhoy JW. Renal actions of angiotensin-(1-7): In vivo and in vitro studies. Am. J. Physiol. 1996 270 : F141 7.
20. Santos RA, Simoes e Silva AC, Magaldi AJ et al. Evidence for a physiological role of angiotensin-(1-7) in the control of hydroelectrolyte balance. Hypertension 1996 27 : 875 84.
21. Chappell MC, Diz DI, Yunis C, Ferrario CM. Differential actions of angiotensin-(1-7) in the kidney. Kidney Int. Suppl. 1998 68 : S3 6.
22. Vauquelin G, Michotte Y, Smolders I et al. Cellular targets for angiotensin II fragments: Pharmacological and molecular evidence. J. Renin Angiotensin Aldosterone Syst. 2002 3 : 195 204.
23. Chappell MC, Pirro NT, Sykes A, Ferrario CM. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension 1998 31 : 362 7.
24. Brand M, Lamande N, Sigmund CD, Larger E, Corvol P, Gasc JM. Angiotensinogen modulates renal vasculature growth. Hypertension 2006 47 : 1067 74.
25. Brosnihan KB, Neves LA, Joyner J et al. Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy. Hypertension 2003 42 : 749 53.
26. Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D. Glomerular localization and expression of angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: Implications for albuminuria in diabetes. J. Am. Soc. Nephrol. 2006 17 : 3067 75.
27. Lely AT, Hamming I, van Goor H, Navis GJ. Renal ACE2 expression in human kidney disease. J. Pathol 2004 204 : 587 93.
28. Tikellis C, Johnston CI, Forbes JM et al. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 2003 41 : 392 7.
29. Zhang H, Wada J, Hida K et al. Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ace2 and is developmentally regulated in embryonic kidneys. J. Biol. Chem. 2001 276 : 17 132 9.
30. Li N, Zimpelmann J, Cheng K, Wilkins JA, Burns KD. The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules. Am. J. Physiol. Renal Physiol. 2005 288 : F353 62.
31. Crackower MA, Sarao R, Oudit GY et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002 417 : 822 8.
32. Doan TN, Gletsu N, Cole J, Bernstein KE. Genetic manipulation of the renin-angiotensin system. Curr. Opin. Nephrol. Hypertens. 2001 10 : 483 91.
33. Oudit GY, Herzenberg AM, Kassiri Z et al. Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am. J. Pathol. 2006 168 : 1808 20.
34. Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am. J. Med. 1982 72 : 375 80.
35. Wolf G, Wenzel U, Hannken T, Stahl RA. Angiotensin II induces p27 (Kip1) expression in renal tubules in vivo: Role of reactive oxygen species. J. Mol. Med. 2001 79 : 382 9.
36. Zatz R, Dunn BR, Meyer TW, Brenner B. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J. Clin. Invest. 1986 77 : 1925 30.
37. Anderson S, Rennke HG, Garcia DL, Brenner BM. Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Inter. 1989 36 : 526 36.
38. Anderson S, Jung FF, Ingelfinger JR. Renal renin-angiotensin system in diabetes: Functional, immunohistochemical, and molecular biological correlations. Am. J. Physiol. 1993 265 : F477 86.
39. Konoshita T, Wakahara S, Mizuno S et al. Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy. Diabetes Care 2006 29 : 848 52.
40. Tikellis C, Cooper ME, Bialkowski K et al. Developmental expression of ACE2 in the SHR kidney: A role in hypertension? Kidney Int. 2006 70 : 34 41.
41. Soler MJ, Wysocki JYeM, Lloveras J, Kanwar Y, Batlle D. ACE2 inhibition worsens glomerular injury associated with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int. 2007 72 : 614 23.
42. Wong DW, Oudit GY, Reich H et al. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am. J Pathol. 2007 171 : 438 51.
43. Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): A randomised controlled trial. Lancet 2003 361 : 117 24.
44. Danilczyk U, Penninger JM. Angiotensin-converting enzyme II in the heart and the kidney. Circ. Res. 2006 98 : 463 71.
45. Cao Z, Bonnet F, Candido R et al. Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury. J. Am. Soc. Nephrol. 2002 13 : 1773 87.
46. Gilbert RE, Wu LL, Kelly DJ et al. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis. Am. J. Pathol. 1999 155 : 429 40.
47. Li P, Chappell MC, Ferrario CM, Brosnihan KB. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension 1997 29 : 394 400.
48. Jaiswal N, Diz DI, Tallant EA, Khosla MC, Ferrario CM. Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells. Am. J. Physiol. 1991 260 : R1000 6.
49. Muthalif MM, Benter IF, Uddin MR, Harper JL, Malik KU. Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells. J. Pharmacol. Exp. Ther. 1998 284 : 388 98.
50. Paula RD, Lima CV, Khosla MC, Santos RA. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension 1995 26 : 1154 9.
51. Brosnihan KB, Li P, Ferrario CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996 27 : 523 8.
52. Iyer SN, Ferrario CM, Chappell MC. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension 1998 31 : 356 61.
53. Stanziola L, Greene LJ, Santos RA. Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats. Am. J. Hypertens. 1999 12 : 1021 9.
54. Yagil Y, Yagil C. Hypothesis: ACE2 modulates blood pressure in the mammalian organism. Hypertension 2003 41 : 871 3.
55. Gurley SB, Allred A, Le TH et al. Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J. Clin. Invest. 2006 116 : 2218 25.
56. Zhong JC, Huang DY, Yang YM et al. Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats. Hypertension 2004 44 : 907 12.
57. Diez-Freire C, Vazquez J, Correa de Adjounian MF et al. ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. Physiol. Genomics 2006 27 : 12 19.
58. Liu TB, Shang HP, Zhang KX et al. [Association of angiotensin I converting enzyme 2 gene polymorphism with essential hypertension in Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005 22 : 569 71.
59. Fan X, Wang Y, Sun K et al. Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of captopril in women. Clin. Pharmacol. Ther. 2007.
60. Benjafield AV, Wang WY, Morris BJ. No association of angiotensin- converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension. Am. J. Hypertens. 2004 17 : 624 8.
61. Frojdo S, Sjolind L, Parkkonen M et al. Polymorphisms in the gene encoding angiotensin I converting enzyme 2 and diabetic nephropathy. Diabetologia 2005 48 : 2278 81.